Press release
Steady Growth and Innovations Bolster Kidney Cancer Drugs Market: Forecasts Reveal Market Size of $10.48 Billion by 2029
Kidney Cancer Drugs Market Size
What Is The Projected Market Size Of The Global Kidney Cancer Drugs Market And Its Growth Rate?
The kidney cancer drugs market has witnessed substantial growth:
• The market expanded from $8.2 billion in 2024 to $8.63 billion in 2025, with a compound annual growth rate (CAGR) of 5.1%.
• Key drivers include increased healthcare expenditure, rapid growth in elderly population, and advances in drug discovery.
• Continued strong performance is expected, with projections pointing to a promising market size of $10.48 billion by 2029 and a CAGR of 5.0%.
• Future growth drivers encompass geriatric population increase, rising healthcare expenditure, drug development partnerships, and the potential of emerging economies.
What Is Driving The Growth In The Kidney Cancer Drugs Market?
The primary catalyst of the upward trend seen in the kidney cancer drugs market is the rising incidence of renal cancer. Unhealthy lifestyles, tobacco usage, and improper diet have led to increasing renal cancer cases, thus propelling the kidney cancer drugs market. For instance, the American Cancer Society predicts 79,000 new kidney cancer diagnoses and 13,920 fatalities due to the disease in 2022 alone. The majority of patients are diagnosed between the ages of 65-74, thus, the rising elderly population further fuels demand for kidney cancer drugs.
https://www.thebusinessresearchcompany.com/sample.aspx?id=2591&type=smp
Who Are the Key Players Driving Kidney Cancer Drugs Market Growth?
Numerous noteworthy entities are driving growth in the kidney cancer drugs market:
• Pfizer Inc.
• Novartis AG
• ExelixisInc.
• F. Hoffmann-La Roche AG
• Bristol Myers Squibb Company
• Bayer AG
• Merck & Co., Inc.
• EUSA Pharma Inc.
• UroGen Pharma Ltd.
• Natco Pharma, and many others
What Are The Key Trends In The Kidney Cancer Drugs Market?
Notable trends are shaping the kidney cancer drugs market:
• Adoption of 3D technology in drug manufacturing and model creation
• Investment in biomarkers
• Launch or adoption of new treatment developments
• Improvement of treatment through personalized medicine
• Investment in AI solutions
• Collaboration and partnerships for accelerating new drug development
What Are The Segments Of The Global Kidney Cancer Drugs Market?
The kidney cancer drugs market report segments the landscape by:
1) Type: Renal Cell Carcinoma (RCC), Transitional Cell Carcinoma (TCC) Or Urothelial Cell Carcinoma (UCC)
2) Product: Nexavar (Sorafenib), Sutent (Sunitinib), Afinitor (Everolimus), Votrient (Pazopanib), Avastin (Bevacizumab), Inlyta (Axitinib), Other Products
3) End Users: Hospitals, Clinics, Research Center, Other End-Users
Which Region Leads The Kidney Cancer Drugs Market?
In 2024, North America dominated the kidney cancer drugs market. However, the Middle East is projected to be the fastest-growing region in the forecast period. The report also covers regions including Asia-Pacific, Western Europe, Eastern Europe, South America, and Africa.
https://www.thebusinessresearchcompany.com/report/kidney-cancer-drugs-global-market-report
What Is Covered In The Kidney Cancer Drugs Market Global Market Report?
- Market Size Analysis: Analyze the Kidney Cancer Drugs Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Kidney Cancer Drugs Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Kidney Cancer Drugs Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities, and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Kidney Cancer Drugs Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
https://www.thebusinessresearchcompany.com/customise?id=2591&type=smp
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Steady Growth and Innovations Bolster Kidney Cancer Drugs Market: Forecasts Reveal Market Size of $10.48 Billion by 2029 here
News-ID: 3837136 • Views: …
More Releases from The Business Research Company
Segmentation, Main Drivers, and Competitive Overview of the Automotive Lane Warn …
The automotive lane warning systems market is poised for substantial expansion in the coming years, driven by rapid technological advancements and increasing safety demands. As the automotive industry embraces smarter and more connected vehicles, these systems are becoming increasingly essential for enhancing road safety and supporting autonomous driving features. Let's explore the projected market size, key players, critical drivers, and the main segments shaping this evolving sector.
Projected Market Size of…
Segment Evaluation and Major Growth Areas in the Automotive Interior Market
The automotive interior market is on track for substantial growth in the coming years, driven by rapid advancements and shifting consumer preferences. As automakers continue to innovate, the interiors of vehicles are evolving to offer enhanced comfort, technology integration, and sustainability. Below, we explore the market's valuation forecast, leading players, key trends, and major segments shaping the industry's future.
Projected Growth and Market Size of the Automotive Interior Industry
The automotive…
Competitive Landscape: Key Market Leaders and New Entrants in the Automotive Hyp …
The automotive hypervisor market is rapidly evolving as vehicles become increasingly software-driven and connected. Advances in autonomous driving and cybersecurity are driving the need for sophisticated virtualization technologies. This overview explores the market's projected growth, key players shaping the landscape, emerging trends, and the main segments fueling expansion.
Automotive Hypervisor Market Size and Growth Forecast Through 2030
The automotive hypervisor market is poised for remarkable expansion, expected to reach a valuation…
Emerging Growth Trends Driving Expansion in the Automotive Human-Machine Interfa …
The automotive human-machine interfaces market is poised for substantial growth as vehicle technology rapidly evolves. With advancements in autonomous driving, electric vehicles, and smart cockpit systems, this sector is set to transform how drivers and passengers interact with their vehicles. Below is a detailed look at the market size, key players, trends driving innovation, and the main segments shaping this industry.
Automotive Human-Machine Interfaces Market Size and Growth Outlook
The automotive…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
